Skip to contents

  1. Al-Batran, Salah-Eddin; Lorenzen, Sylvie; Thuss-Patience, Peter C.; Homann, Nils; Schenk, Michael; Lindig, Udo; Heuer, Vera; Kretzschmar, Albrecht; Goekkurt, Eray; Haag, Georg Martin; Riera-Knorrenschild, Jorge; Bolling, Claus; Hofheinz, Ralf-Dieter; Angermeier, Stefan; Ettrich, Thomas Jens; Siebenhuener, Alexander Reinhard; Kopp, Christina; Pauligk, Claudia; Goetze, Thorsten Oliver

    A randomized, open-label, phase II/III efficacy and safety study of atezolizumab in combination with FLOT versus FLOT alone in patients with gastric cancer and adenocarcinoma of the oesophagogastric junction and high immune responsiveness: The IKF-S633/DANTE trial, a trial of AIO in collaboration with SAKK

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2023

    Published in: Journal of Clinical Oncology

  2. Lorenzen, Sylvie; Thuss-Patience, Peter C.; Riera Knorrenschild, Jorge; Goekkurt, Eray; Dechow, Tobias Nicolaas; Hofheinz, Ralf-Dieter; Luley, Kim Barbara; Ettrich, Thomas Jens; Pink, Daniel; Lindig, Udo; Folprecht, Gunnar; Schuch, Gunter; Bitzer, Michael; Bolling, Claus; Homann, Nils; Junge, Sabine; Pauligk, Claudia; Gaiser, Timo; Goetze, Thorsten Oliver; Al-Batran, Salah-Eddin

    FOLFOX versus FOLFOX plus nivolumab and ipilimumab administered in parallel or sequentially versus FLOT plus nivolumab administered in parallel in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: A randomized phase 2 trial of the AIO

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2022

    Published in: Journal of Clinical Oncology

  3. Ebert, Matthias P; Meindl-Beinker, Nadja M; Gutting, Tobias; Maenz, Martin; Betge, Johannes; Schulte, Nadine; Zhan, Tianzuo; Weidner, Philip; Burgermeister, Elke; Hofheinz, Ralf; Vogel, Arndt; Angermeier, Stefan; Bolling, Claus; de Wit, Maike; Jakobs, Ralf; Karthaus, Meinolf; Stocker, Gertraud; Thuss-Patience, Peter; Leidig, Tobias; Gaiser, Timo; Kather, Jakob N; Haertel, Nicolai

    Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Elsevier BV, 2022

    Published in: The Lancet Healthy Longevity

  4. Al-Batran, Salah-Eddin; Lorenzen, Sylvie; Thuss-Patience, Peter C.; Homann, Nils; Schenk, Michael; Lindig, Udo; Heuer, Vera; Kretzschmar, Albrecht; Goekkurt, Eray; Haag, Georg Martin; Riera Knorrenschild, Jorge; Bolling, Claus; Hofheinz, Ralf-Dieter; Angermeier, Stefan; Ettrich, Thomas Jens; Siebenhuener, Alexander; Kopp, Christina; Pauligk, Claudia; Goetze, Thorsten Oliver; Gaiser, Timo

    Surgical and pathological outcome, and pathological regression, in patients receiving perioperative atezolizumab in combination with FLOT chemotherapy versus FLOT alone for resectable esophagogastric adenocarcinoma: Interim results from DANTE, a randomized, multicenter, phase IIb trial of the FLOT-AIO German Gastric Cancer Group and Swiss SAKK

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2022

    Published in: Journal of Clinical Oncology

  5. Al-Batran, Salah-Eddin; Reichart, Alexander; Bankstahl, Ulli Simone; Pauligk, Claudia; Kraus, Thomas Werner; Bechstein, Wolf Otto; Trojan, Jorg; Behrend, Matthias; Potenberg, Jochem; Homann, Nils; Venerito, Marino; Bohle, Wolfram; Varvenne, Michael; Bolling, Claus; Behringer, Dirk M.; Kratz-Alber, Karsten; Siegler, Gabriele Margareta; Hozaeel, Wael; Goetze, Thorsten Oliver

    Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2021

    Published in: Journal of Clinical Oncology

  6. Homann, Nils; Lorenzen, Sylvie; Schenk, Michael; Thuss-Patience, Peter C.; Goekkurt, Eray; Hofheinz, Ralf Dieter; Kretzschmar, Albrecht; Bolling, Claus; Angermeier, Stefan; Wicki, Andreas; Siebenhuener, Alexander Rheinhard; Lindig, Udo; Pink, Daniel; Ettrich, Thomas Jens; Schmalenberg, Harald; Waberer, Lisa; Talbot, Jonathan; Pauligk, Claudia; Goetze, Thorsten Oliver; Al-Batran, Salah-Eddin

    Interim safety analysis of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma—A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2020

    Published in: Journal of Clinical Oncology

  7. Al-Batran, Salah-Eddin; Lorenzen, Sylvie; Schenk, Michael; Thuss-Patience, Peter C.; Goekkurt, Eray; Hofheinz, Ralf; Kretzschmar, Albrecht; Bolling, Claus; Angermeier, Stefan; Wicki, Andreas; Siebenhuener, Alexander Rheinhard; Eigendorff, Ekkehard; Pink, Christin; Ettrich, Thomas Jens; Schmalenberg, Harald; Waberer, Lisa; Talbot, Jonathan; Pauligk, Claudia; Goetze, Thorsten Oliver; Homann, Nils

    Safety of perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: An interim safety analysis of the DANTE, a randomized, open-label phase II trial of the German Gastric Group at the AIO and the SAKK

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    American Society of Clinical Oncology (ASCO), 2020

    Published in: Journal of Clinical Oncology

  8. Al-Batran, Salah-Eddin; Goetze, Thorsten O.; Mueller, Daniel W.; Vogel, Arndt; Winkler, Michael; Lorenzen, Sylvie; Novotny, Alexander; Pauligk, Claudia; Homann, Nils; Jungbluth, Thomas; Reissfelder, Christoph; Caca, Karel; Retter, Steffen; Horndasch, Eva; Gumpp, Julia; Bolling, Claus; Fuchs, Karl-Hermann; Blau, Wolfgang; Padberg, Winfried; Pohl, Michael; Wunsch, Andreas; Michl, Patrick; Mannes, Frank; Schwarzbach, Matthias; [...]

    The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI

    Articles
    View online
    Schließen

    Access

    Close

    Bookmarks

    You can manage bookmarks using lists, please log in to your user account for this.

    Springer Science and Business Media LLC, 2017

    Published in: BMC Cancer